Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study

Timothy Davis; D. Jackson; M. Balme; David Bruce

Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study

Timothy Davis, D. Jackson, M. Balme, David Bruce

Research output: Chapter in Book/Conference paper › Conference paper

Original language	English
Title of host publication	EASD
Editors	W. Waldhausl
Place of Publication	Austria
Publisher	Diabetologica
Pages	A225
Volume	42
Edition	Brussels
ISBN (Print)	0012186X
Publication status	Published - 1999
Event	Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study - Brussels Duration: 1 Jan 1999 → …

Conference

Conference	Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study
Period	1/01/99 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@inproceedings{220941bb80cc498bb551d0ad3cd73f70,

title = "Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study",

author = "Timothy Davis and D. Jackson and M. Balme and David Bruce",

year = "1999",

language = "English",

isbn = "0012186X",

volume = "42",

pages = "A225",

editor = "W. Waldhausl",

booktitle = "EASD",

publisher = "Diabetologica",

edition = "Brussels",

note = "Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study ; Conference date: 01-01-1999",

}

TY - GEN

T1 - Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study

AU - Davis, Timothy

AU - Jackson, D.

AU - Balme, M.

AU - Bruce, David

PY - 1999

Y1 - 1999

M3 - Conference paper

SN - 0012186X

VL - 42

SP - A225

BT - EASD

A2 - Waldhausl, W.

PB - Diabetologica

CY - Austria

T2 - Prevalence of, and risk factors for, hyperlactaemia in metformin-treated patients: The Fremantle Diabetes Study

Y2 - 1 January 1999

ER -